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Chronic obstruction of the urinary tract is associ-
ated with marked alterations in glomerular filtration
rate (GFR) and renal blood flow (RBF) [1—3]. Al-
though many factors undoubtedly contribute to the
alterations in vascular resistance and hemodynam-
ics in the chronic phases of obstruction, there is
evidence that following acute ureteral obstruction
functional changes may be mediated through the
prostaglandin system. Elevation of ureteral pres-
sure in the cat [4] inhibits vasoconstriction elicited
by neuronal stimulation and exogenous catechol-
amines. These inhibitory effects were negated by
inhibition of cyclooxygenase activity with the non-
steroidal antiinflammatory drug indomethacin, thus
suggesting that the acute effects of ureteral pressure
elevation on renal vascular resistance were in part
mediated by stimulated prostaglandin biosynthesis.
Further evidence suggesting a role for dilator pros-
taglandins in these events was obtained by Allen,
Vaughn, and Gillenwater, [51 who showed that with
indomethacin pretreatment followed by ligation of
the ureter in the dog there is a fall in total RBF, and
the characteristic ipsilateral renal vasodilation does
not occur. But although the presence of a dilator
prostaglandin may explain the changes in blood
flow occurring the first 4 to 5 hours, it does not
explain the fall in blood flow occurring in both the
rat [6] and dog [7] by 18 to 24 hours after ureteral
occlusion. Therefore, we have tried to define both
qualitatively and quantitatively the nature of the
biochemical events, the factors controlling the syn-
thesis and release of prostaglandins from the kid-
ney, and the potential role for prostaglandins in
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controlling renal hemodynamics following unilater-
al ureteral obstruction and glycerol-induced acute
renal failure. The latter model was chosen because
one of the mechanisms invoked for the fall of GFR
is intratubular obstruction.
Renal prostaglandin biosynthesis
Prostaglandins are not stored. Thus, release rep-
resents de novo synthesis from precursor pools
through a series of enzymatic processes. Arachi-
donic acid is released from endogenous phospho-
lipid pools probably through the activation of a
phosphatide acyl hydrolase that cleaves the ester
linkage at the f3 position of the phospholipid. This
step is one of the rate-limiting steps in pros taglandin
biosynthesis and serves to provide the substrate for
the cyclooxygenase, a microsomal enzyme that
generates the unstable key intermediate endoperox-
ide PGH2. PGH2 can then be converted enzymati-
cally to the biologically active prostanoids PGE2,
PGF2a, thromboxane A2, and PGI2. The sites of
synthesis of the biologically active prostaglandins
are distributed throughout the kidney, and prosta-
glandins probably exert their effects close to their
sites of synthesis. There appear to be at least three
different parts of the kidney capable of prostaglan-
din biosynthesis (a) the glomerulus [8, 9] and affer-
ent arteriole [10], (b) the medullary collecting duct
[11], and (c) the medullary interstitial cells [12, 13].
Prostaglandin biosynthesis in experimental ureteral
obstruction
Unilateral ureteral obstruction in the rabbit for 3
days causes an enhanced basal and hormonal (angi-
otensin II [All], bradykinin, and norepinephrine)
stimulated prostaglandin biosynthesis [14], as evi-
denced by a shift to the left of the dose-response
curves in the perfused, ureter-obstructed kidney
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Fig. 1. Dose-response curves for angiotensin 11 and bradykinin
in hydronephrotic (HNK), normal (NORM), and contralateral
kidneys (CLK). Vertical axis represents prostaglandin (PG)-like
material released in nanograms as detected by bioassay.
(Fig. 1) when compared with the contralateral kid-
ney or a normal kidney. Thus, we could demon-
strate by bioassay an enhanced release of biologi-
cally active substances from the perfused hydro-
nephrotic kidney. In these experiments, we were
able to monitor perfusion pressure in a constant
flow system such that changes in resistance were
reflected by changes in perfusion pressure. Under
the conditions of the experiment it was observed
that indomethacin treatment of the perfused ureter-
al-obstructed kidney increased the basal perfusion
pressure and markedly enhanced the response to
the vasoconstrictor All. These results suggested
that the basal resistance of the perfused kidney was
under the influence of a dilator prostaglandin and
that the response to All was being modulated by a
dilator prostaglandin. But when bradykinin was
used as an agonist, we frequently (more than 80% of
the time) noted that the perfusion pressure, which
always fell in the normal or contralateral kidney,
increased in the hydronephrotic kidney. This led us
to include other assay organs (for example, rabbit
aorta, which is sensitive to thromboxane A2; and
bovine coronary artery, which is sensitive to PGI2)
in the cascade system in an attempt to detect the
release of other biologically active prostaglandins.
Figure 2 shows an example of such an experiment.
Here the assay organs are the bovine coronary
artery (BCA), the rabbit thoracic aorta (RA), and
the rat fundal stomach strip (RSS), the latter assay
organ being sensitive to PGE2. This figure shows
that coincident with an increase in perfusion pres-
sure with 200 ng of bradykinin injected through the
kidney there was the release of substances that
Fig. 2. Contractions and relaxations of bovine coronary artery
(BCA), rabbit aorta (RA), and rat fundal stomach strip (RSS).
The prostaglandins are released into perfusion media and super-
fused over assay organs. Simultaneous perfusion pressure (PP) is
also recorded. DIR denotes directly over assay organs; TK,
through the kidney.
contracted the rabbit aorta and relaxed the bovine
coronary artery and suggested that the ureteral
obstructed kidney was releasing both thromboxane
A2 and PGI2. Of some significance was a constrictor
response produced by bradykinin that was abol-
ished by indomethacin pretreatment of the kidney,
confirming the dependency on cyclooxygenase. Ev-
idence that the ureteral-obstructed kidney could
generate thromboxane A2 was also obtained from in
vitro experiments [15, 16]. Incubations of the endo-
peroxide PGH2 with microsomal preparations(x l00,000g pellet) of renal cortex and medulla
produced a compound that caused marked contrac-
tion of rabbit aorta, which had a biological t½ of
about 40 sec at 370 C in aqueous media, and the
enzymatic synthesis of which was blocked by imid-
azole, a thromboxane synthetase inhibitor [7]. Fur-
ther evidence for synthesis was shown by radio-
chemical conversion of '4C-arachidonate to '4C-
thromboxane B2 that could be inhibited with
imidazole. In the normal or contralateral kidneys,
we could not demonstrate biologically, enzymati-
cally, or radiochemically the presence of the throm-
boxane synthetic pathway. Further experiments
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Fig. 3. Hematoxylin-eosin micrograph of isolated glomeruli (x350).
designed to evaluate the sites along the synthetic
cascade at which these changes might be occurring
suggested that ureteral obstruction was associated
with de novo protein synthesis that could be
blocked by actinomycin D and cycloheximide. The
localization of the synthesis of new enzyme was at
the level of phosphatide acyl hydrolase [18] and
cyclooxygenase [19], and these changes could be
further accentuated during perfusion ex vivo of the
isolated kidneys. More recently, in an attempt to
localize the sites of this enhanced synthesis, we
have isolated glomeruli (Fig. 3) and tubules from the
rabbit cortex and have assessed radiochemical con-
version of exogenous arachidonate and radioim-
munoassayable prostaglandin release from endoge-
nous sources. The data suggest that although we
could not detect any differences in glomeruli isolat-
ed from contralateral and hydronephrotic kidneys,
the tubules from the hydronephrotic kidneys
showed a modest increase in thromboxane A2 and
PGE2 but not PGI2 (Fig. 4) production. Thus,
changes in TXB2 and PGE2 production in these
units of the cortex may, in part, explain the quanti-
tative and qualitatve alterations seen in prostaglan-
din biosynthesis following ureteral obstruction.
Thromboxane A2 production in glycerol-induced acute
renal failure
One of the hypotheses suggested to explain the
fall in GFR in glycerol-induced acute renal failure
has been intratubular obstruction with myoglobin
casts in the tubules. Because of the observations in
the ureteral-obstructed model, we set out to deter-
mine if there were also qualitative and quantitative
changes in prostaglandin biosynthesis in kidneys
from rabbits in which renal failure had been induced
by glycerol. In these experiments, rabbits were
administered 14 ml/kg of 50% glycerol in saline s.c.
Serum samples for creatinine were obtained prior to
the administration of glycerol and 24 hours later on
the day of study. The kidneys were then perfused,
and the effluent was assayed by superfusion cas-
cade using smooth muscle assay organs [18]. These
experiments showed that rabbits, which were in
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Fig. 4. Immunoassayable 6-keto PGF,, (6-KPGF1j, PGE2, and
thromboxane B2 (TxB2) produced by glomerular (G) and tubular
preparations (T). HNK denotes hydronephrotic (N = 5).
acute renal failure as indicated by an elevated
serum creatinine, released into the perfusate a
substance that contracted the rabbit aorta and that
was inhibited by indomethacin. Furthermore, there
was an inverse correlation between the serum creat-
mine and the dose of bradykinin required to stimu-
late the release of a substance that caused a stan-
dard contraction of the rabbit aorta. By gas chroma-
tography mass spectometry, we could demonstrate
the release of TxB2 into the perfusate in response to
All and bradykinin. These experiments were fur-
ther expanded to show that microsomal prepara-
tions of cortex and medulla had the capacity to
convert arachidonic acid to classic prostaglandins
and thromboxane A2, and this conversion could be
inhibited by imidazole. In addition, we could dem-
onstrate that there was a correlation between the
percentage of arachidonic acid converted to throm-
boxane A2 and the concentration of the serum
creatinine. Thus, although our experimental design
did not allow us to draw any conclusions about the
effects of thromboxane A2 production on RBF,
nevertheless there seemed to be a direct correlation
between the metabolic potential for thromboxane
A2 biosynthesis and the serum creatinine. Some
suggestion of a potential effect of thromboxane A2
production on renal vascular resistance was indicat-
ed by the responses of the perfusion pressure to
bradykinin stimulation. Bradykinin injected into a
normal rabbit kidney perfused ex vivo produced a
dose-dependent fall in perfusion pressure. These
effects were due to both direct effects of the hor-
mone [19] and released PGE2 [20]. On the other
hand, we observed variable responses in the per-
fused kidneys obtained from glycerol-treated rab-
bits. Figure 5 shows an example of the change in
perfusion pressure occurring in response to 500 ng
of bradykinin injected into the kidney prior to and
100r (5.2 mg/dl(E 50F-
a. 0L
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after indomethacin treatment. Here, the responses
from a kidney of a rabbit with a creatinine concen-
tration of 1.2 mgldl (normal, 0.9 mg/dl) are com-
pared with the responses from a kidney of a rabbit
whose creatinine concentration was 5.2 mg/dl. In
the kidney from the rabbit with a creatinine concen-
tration of 5.2 mg/dl, bradykinin caused an increase
in perfusion pressure, indicating an increase in
resistance that was abolished by indomethacin. In
the kidney from the rabbit with a creatinine concen-
tration of 1.2 mg/dl, 500 ng of bradykinin did not
elicit an increase in resistance prior to or after
indomethacin treatment. All the kidneys that had an
increased resistance in response to bradykinin came
from rabbits with high creatinine concentrations.
But, not all kidneys from rabbits with high creati-
nine concentrations showed an increased perfusion
pressure following bradykinin. Thus, although the
responses were variable, they nevertheless suggest
a potential role for thromboxane A2 in modulating
vascular resistance in experimental glycerol-in-
duced acute renal failure.
Thus, in the two models of renal pathophysiology
described, there are marked biochemical alterations
in renal prostaglandin biosynthesis with the produc-
tion of thromboxane A2, as well as increased
amounts of other prostaglandins. Recently, Zipser,
Myers, and Needleman [23] have described a
marked increase in thromboxane A2 production in a
model of partial renal venous occlusion, and this
again underscores the effect of renal pathophysiol-
ogy on endogenous prostaglandin biosynthesis. Al-
though our in vitro results suggest a potential role
for these vasoactive agents in renal hemodynamics,
the true biological importance of these compounds
as mediators of vascular tone must await in vivo
experiments.
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Fig. 5. Perfusion-pressure (PP) recordings of rabbit kidney
before and after treatment with indomethacin (INDO). Scr is
serum creatinine concentration.
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